Goldman Sachs
STML

Goldman Sachs’s Stemline Therapeutics, Inc. STML Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,905,276
Closed -$9.22M 4667
2020
Q1
$9.22M Buy
1,905,276
+551,588
+41% +$2.67M ﹤0.01% 1843
2019
Q4
$14.4M Sell
1,353,688
-23,769
-2% -$253K ﹤0.01% 1826
2019
Q3
$14.3M Sell
1,377,457
-97,196
-7% -$1.01M ﹤0.01% 1745
2019
Q2
$22.6M Buy
1,474,653
+110,685
+8% +$1.7M 0.01% 1501
2019
Q1
$17.5M Buy
1,363,968
+1,324,590
+3,364% +$17M 0.01% 1700
2018
Q4
$374K Buy
39,378
+19,798
+101% +$188K ﹤0.01% 3523
2018
Q3
$325K Sell
19,580
-4,003
-17% -$66.4K ﹤0.01% 3639
2018
Q2
$379K Buy
23,583
+1,822
+8% +$29.3K ﹤0.01% 3638
2018
Q1
$333K Buy
+21,761
New +$333K ﹤0.01% 3665
2017
Q4
Sell
-37,422
Closed -$415K 4387
2017
Q3
$415K Buy
+37,422
New +$415K ﹤0.01% 3587
2016
Q4
Sell
-12,158
Closed -$132K 4622
2016
Q3
$132K Buy
+12,158
New +$132K ﹤0.01% 4096
2016
Q2
Sell
-11,592
Closed -$54K 4707
2016
Q1
$54K Sell
11,592
-5,466
-32% -$25.5K ﹤0.01% 4198
2015
Q4
$108K Sell
17,058
-449,418
-96% -$2.85M ﹤0.01% 3962
2015
Q3
$4.12M Buy
466,476
+5,548
+1% +$49K ﹤0.01% 2127
2015
Q2
$5.43M Sell
460,928
-871
-0.2% -$10.3K ﹤0.01% 2027
2015
Q1
$6.68M Sell
461,799
-19,712
-4% -$285K ﹤0.01% 1873
2014
Q4
$8.21M Buy
481,511
+185,094
+62% +$3.16M ﹤0.01% 1701
2014
Q3
$3.69M Sell
296,417
-34,497
-10% -$430K ﹤0.01% 2168
2014
Q2
$4.86M Buy
330,914
+75,888
+30% +$1.11M ﹤0.01% 2021
2014
Q1
$5.19M Buy
255,026
+34,763
+16% +$708K ﹤0.01% 1962
2013
Q4
$4.32M Sell
220,263
-590
-0.3% -$11.6K ﹤0.01% 2091
2013
Q3
$10M Buy
220,853
+175,026
+382% +$7.93M ﹤0.01% 1488
2013
Q2
$1.09M Buy
+45,827
New +$1.09M ﹤0.01% 2759